Recombinant multi-species KLF5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KLF5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the Kruppel-like factor subfamily of zinc finger proteins. The encoded protein is a transcriptional activator that binds directly to a specific recognition motif in the promoters of target genes. This protein acts downstream of multiple different signaling pathways and is regulated by post-translational modification. It may participate in both promoting and suppressing cell proliferation. Expression of this gene may be changed in a variety of different cancers and in cardiovascular disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2013]
The Alternative Names of target: 4930520J07Rik,BTEB2,Basic transcription element-binding protein 2 (BTE-binding protein 2),Bteb2,CKLF,Colon krueppel-like factor,GC-box-binding protein 2,IKLF,Intestinal-enriched krueppel-like factor,KLF5,Klf5,Krueppel-like factor 5,Transcription factor BTEB2,bteb2

Target products collectionGo to KLF5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP11611-Ag-1/ GM-Tg-hg-IP11611-Ag-2 Human KLF5 protein Human
GM-Tg-rg-IP11611-Ag-1/ GM-Tg-rg-IP11611-Ag-2 Rat KLF5 protein Rat
GM-Tg-mg-IP11611-Ag-1/ GM-Tg-mg-IP11611-Ag-2 Mouse KLF5 protein Mouse
GM-Tg-cynog-IP11611-Ag-1/ GM-Tg-cynog-IP11611-Ag-2 Cynomolgus/Rhesus macaque KLF5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP11611-Ag-1/ GM-Tg-felg-IP11611-Ag-2 Feline KLF5 protein Feline
GM-Tg-cang-IP11611-Ag-1/ GM-Tg-cang-IP11611-Ag-2 Canine KLF5 protein Canine
GM-Tg-bovg-IP11611-Ag-1/ GM-Tg-bovg-IP11611-Ag-2 Bovine KLF5 protein Bovine
GM-Tg-equg-IP11611-Ag-1/ GM-Tg-equg-IP11611-Ag-2 Equine KLF5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP11611-Ag-1/ GM-Tg-hg-IP11611-Ag-2; GM-Tg-rg-IP11611-Ag-1/ GM-Tg-rg-IP11611-Ag-2;
GM-Tg-mg-IP11611-Ag-1/ GM-Tg-mg-IP11611-Ag-2; GM-Tg-cynog-IP11611-Ag-1/ GM-Tg-cynog-IP11611-Ag-2;
GM-Tg-felg-IP11611-Ag-1/ GM-Tg-felg-IP11611-Ag-2; GM-Tg-cang-IP11611-Ag-1/ GM-Tg-cang-IP11611-Ag-2;
GM-Tg-bovg-IP11611-Ag-1/ GM-Tg-bovg-IP11611-Ag-2; GM-Tg-equg-IP11611-Ag-1/ GM-Tg-equg-IP11611-Ag-2
Products Name KLF5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name KLF5
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine KLF5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.